Sunday, October 4, 2026
Home Authors Posts by Ogkologos

Ogkologos

4358 POSTS 0 COMMENTS

ESMO Announces 2026 Society Award Recipients Honouring Excellence in Cancer Research,...

Ogkologos -
0

ESMO Announces 2026 Fellowship Recipients Supporting Innovation in Cancer Research, Artificial...

Ogkologos -
0

First-Line Nivolumab Plus Chemotherapy and Nivolumab Plus Ipilimumab Continue to Demonstrate...

Ogkologos -
0

Adjuvant Olaparib Continues to Improve Multiple Outcomes in Patients with Germline...

Ogkologos -
0

New Translations of the ESMO Patient Guides Available in Estonian

Ogkologos -
0

Aiming to Support Cancer Research, ESMO Calls on the European Council...

Ogkologos -
0

EMA Recommends Refusing the Marketing Authorisation for Copper (64Cu) Oxodotreotide

Ogkologos -
0

Trend in Survival Benefit with a Combination of Spartalizumab Plus Dabrafenib...

Ogkologos -
0

FDA Approves Pembrolizumab or Pembrolizumab and Berahyaluronidase alfa-pmph Each with Enfortumab...

Ogkologos -
0

Enzalutamide Continues to Provide Substantial Long-Term OS Benefit at 8 Years...

Ogkologos -
0
1...345...436Page 4 of 436

MOST POPULAR

Load more

HOT NEWS

Follow us on Instagram @ogkologos

Το πρώτο ολοκληρωμένο portal για τον καρκίνο. Ενημερωθείτε για τον καρκίνο, καθώς και για τις τελευταίες εξελίξεις.
Contact us: info@ogkologos.com

POPULAR POSTS

POPULAR CATEGORY

Copyright © 2023 Ogkologos.com